Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sctv01c
- Development stage
- Phase 3
- Lead developer
- Sinocelltech
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
SCTV01C is a bivalent recombinant trimeric spike protein subunit vaccine developed by Sinocelltech for the prevention of COVID-19. It targets the spike protein ectodomain sequences of both the Alpha (B.1.1.7) and Beta (B.1.351) SARS-CoV-2 variants, aiming to induce broad immune responses against multiple circulating strains[4][9][10]. The vaccine is administered via intramuscular injection and has been evaluated in clinical trials as a booster for individuals previously vaccinated with mRNA COVID-19 vaccines[3][6]. SCTV01C has demonstrated safety and immunogenicity in healthy adults, with robust cross-neutralizing antibody responses against Delta and Omicron variants following heterologous boosting[6].
02
Targets
BVDV E2 (Bovine viral diarrhea virus glycoprotein E2)SARS-CoV-2 spike
Beyond the preview
Go deeper on sctv01c.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sctv01c.